Collagen

Biodegradable Polymers in Clinical Use and Clinical Development

Volumn , Issue , 2011, Pages 59-89

  Khan, Wahid ^a   Yadav, Deepak ^a   Domb, Abraham J ^b   Kumar, Neeraj ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Biodegradable polymers of natural origin protein based polymers, collagen as structural building blocks of body; Clinical applications of collagen, and collagen based biomaterials in tissue engineering and medical applications; Collagen biosynthesis, stability of tissues and organs and structural integrity

Indexed keywords

EID: 84886550376     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118015810.ch2     Document Type: Chapter

References (87)

1. Kadler, K.E., A. Hill, and E.G. Canty-Laird. Collagen fibrillogenesis: Fibronectin, integrins, and minor collagens as organizers and nucleators. Curr. Opin. in Cell Biol. 2008;20(5):495-501.
2. Gelse, K., E. Pöschl, and T. Aigner. Collagens-structure, function, and biosynthesis. Adv. Drug Deliv. Rev. 2003;55(12):1531-1546.
3. O'Grady, J.E. and D.M. Bordon. Global regulatory registration requirements for collagen-based combination products: Points to consider. Adv. Drug Deliv. Rev. 2003;55(12):1699-1721.
4. Aigner, T. and J. Stöve. Collagens-major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv. Drug Deliv. Rev. 2003;55(12):1569-1593.
5. Kanematsu, A., A. Marui, S. Yamamoto, M. Ozeki, Y. Hirano, M. Yamamoto, O. Ogawa, M. Komeda, and Y. Tabata. Type I collagen can function as a reservoir of basic fibroblast growth factor.J. Control. Release 2004;99(2):281-292.
6. Kadler, K.E., D.F. Holmes, J.A. Trotter, and J.A. Chapman. Collagen fibril formation. Biochem.J. 1996;316(Pt 1):1.
7. Peter, H.B. and G.C. William. Osteogenesis imperfecta. In Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects, 2nd ed. P.M. Royce and B. Steinmann (Eds.). John Wiley & Sons: New Jersey, USA, 2003, pp. 385-430.
8. Kadler K.E., C. Baldock, J. Bella, and R.P. Boot-Handford. Collagens at a glance.J. Cell Sci. 2007;120(12):1955.
9. Traub, W., K.A. Piez, C.B. Anfinsen, and M.R. Frederic. The Chemistry and Structure of Collagen. Advances in Protein Chemistry. Academic Press: New York, 1971, pp. 243-352.
10. Prockop, D.J., R.A. Berg, K.I. Kivirikko, J. Uitto, G.N. Ramachandran, and A.H. Reddi. Biochemistry of collagen.G. N. Ramachandran and A.H. Reddi (Eds.). Plenum: New York, 1976, pp. 163-273.
11. Wess, T.J., and J.P. Orgel. Changes in collagen structure: Drying, dehydrothermal treatment and relation to long term deterioration. Thermochim. Acta. 2000;365 (1-2):119-128.
12. Koopmans, G., B. Hasse, N. Sinis, G. Stefano, T. Pierluigi, and B. Bruno. The role of collagen in peripheral nerve repair. In International Review of Neurobiology. Academic Press: San Diego, 2009, pp. 363-379.
13. Pins, G.D., D.L. Christiansen, R. Patel, and F.H. Silver. Self-assembly of collagen fibers. Influence of fibrillar alignment and decorin on mechanical properties. Biophys.J. 1997;73(4):2164-2172.
14. Orgel, J.A. Miller, T.C. Irving, R.F. Fischetti, A.P. Hammersley, and T.J. Wess. The in situ supermolecular structure of type I collagen. Structure 2001; 9(11):1061-1069.
15. Cao, H. and S.Y. Xu. Purification and characterization of type II collagen from chick sternal cartilage. Food Chem. 2008;108:439-445.
16. Barnard, K., L.J. Gathercole, and A.J. Bailey. Basement membrane collagen-evidence for a novel molecular packing. FEBS Lett. 1987;212(1):49-52.
17. Myllyharju, J. and K.I. Kivirikko. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. 2004;20(1):33-43.
18. Fox, M.A. Novel roles for collagens in wiring the vertebrate nervous system. Curr. Opin. Cell Biol. 2008;20(5):508-513.
19. Ihanamäki, T., L.J. Pelliniemi, and E. Vuorio. Collagens and collagen-related matrix components in the human and mouse eye. Prog Retinal Eye Res. 2004;23(4): 403-434.
20. Prockop, J.D. Collagens: Molecular biology, diseases, and potentials for therapy. Ann. Rev. Biochem. 1995;64(1):403-434.
21. Kietty, C.M. and M.E. Grant. The collagen family: Structure, assembly, and organization in the extracellular matrix. In P.M. Royce and B. Steinmann (Eds.). Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects, 2nd ed. John Wiley & Sons, New Jersey, USA, 2003, pp. 159-221.
22. Piez, K.A. Structure and assembly of the native collagen fibril. Connect. Tissue Res. 1982;10(1):25-36.
23. Ramachandran, G.N. and C. Ramakrishnan. Molecular structure. Biochem. Collagen 1972;172:45-84.
24. Berg, R.A. and D.J. Prockop. The thermal transition of a non-hydroxylated form of collagen. Evidence for a role for hydroxyproline in stabilizing the triple-helix of collagen. Biochem. Biophy. Res. Commun. 1973;52(1):115-120.
25. Jimenez, S., M. Harsch, and J. Rosenbloom. Hydroxyproline stabilizes the triple helix of chick tendon collagen. Biochem. Biophys. Res. Commun. 1973;52(1): 106-114.
26. Eyre, D.R. Collagen: Molecular diversity in the body's protein scaffold. Science 1980;207(4437):1315.
27. Bann, J.G., D.H. Peyton, and H.P. Bächinger. Sweet is stable: Glycosylation stabilizes collagen. FEBS Lett. 2000;473(2):237-240.
28. Stricklin, G.P., M.S. Hibbs, and M.E. Nimmi (Eds.). Collagen. 1988; CRC Press, Boca Ratan.
29. Everts V., E. van der Zee, L. Creemers, and W. Beertsen. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem.J. 1996;28(4):229-245.
30. Kucharz, E.J., andF.M. Pope (Eds.). TheCollagens:Biochemistryand Pathophysiology. Springer-Verlag: Berlin, Germany, 1992.
31. Sabeh, F., I. Ota, K. Holmbeck, H. Birkedal-Hansen, P. Soloway, M. Balbin, C. Lopez-Otin, S. Shapiro, M. Inada, S. Krane, E. Allen, D. Chung, and S.J. Weiss. Tumor cell traffic through the extracellular matrix is controlled by the membraneanchored collagenase MT1-MMP.J. Cell Biol. 2004;167(4):769-781.
32. Yang, Y., X. Li, N. Yan, S. Cai, and X. Liu. Myopia: A collagen disease? Med. Hypoth. 2009;73(4):485-487.
33. Ogawa, M., R.J. Portier, M.W. Moody, J. Bell, M.A. Schexnayder, and J.N. Losso. Biochemical properties of bone and scale collagens isolated from the subtropical fish black drum (Pogonia cromis) and sheepshead seabream (Archosargus probatocephalus). Food Chem. 2004;88(4):495-501.
34. Lee, C.H., A. Singla, and Y. Lee. Biomedical applications of collagen. Int.J. Pharm. 2001;221(1-2):1-22.
35. Sano, A., T. Hojo, M. Maeda, and K. Fujioka. Protein release from collagen matrices. Adv. Drug Deliv. Rev. 1998;31(3):247-266.
36. Wang, B., K.Y. Wang, and Y. Ye. [Study status of collagen-based biomaterials in drug release and tissue engineering]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2004;18(2):112-114.
37. Beer, K. Dermal fillers and combinations of fillers for facial rejuvenation. Dermatol. Clin. 2009;27(4):427-432.
38. Smith, K.C. Reversible vs. nonreversible fillers in facial aesthetics: Concerns and considerations. Dermatol. Online J. 2008;14(8):3.
39. Cockerham, K. and V.J. Hsu. Collagen-based dermal fillers: past, present, future. Facial Plast. Surg. 2009;25(2):106-113.
40. Bauman, L. CosmoDerm/CosmoPlast (human bioengineered collagen) for the aging face. Facial Plast. Surg. 2004;20(2):125-128.
41. Monstrey, S.J., S. Pitaru, M. Hamdi, K. Van Landuyt, P. Blondeel, J. Shiri, A. Goldlust, and D. Shoshani. A two-stage phase I trial of Evolence30 collagen for soft-tissue contour correction. Plast. Reconstr. Surg. 2007;120(1):303-311.
42. Pitaru, S., M. Noff, L. Blok, E. Nir, S. Pitaru, A. Goldlust, and N. Savion. Longterm efficacy of a novel ribose-cross-linked collagen dermal filler: a histologic and histomorphometric study in an animal model. Dermatol. Surg. 2007;33 (9):1045-1054; discussion 1054.
43. Smith, K.C. New fillers for the new man. Dermatol. Ther. 2007;20(6):388-393.
44. Grunebaum, L.D., I. Bogdan Allemann, S. Dayan, S. Mandy, and L. Baumann. The risk of alar necrosis associated with dermal filler injection. Dermatol. Surg. 2009;35(Suppl 2):1635-1640.
45. Hirsch, R.J. and M. Stier. Complications of soft tissue augmentation.J. Drugs Dermatol. 2008;7(9):841-845.
46. Boateng, J.S., K.H. Matthews, H.N. Stevens, and G.M. Eccleston. Wound healing dressings and drug delivery systems: A review.J. Pharm. Sci. 2008; 97(8): 2892-2923.
47. Jesty, J., M. Wieland, and J. Niemiec. Assessment in vitro of the active hemostatic properties of wound dressings.J. Biomed. Mater. Res. B Appl. Biomater. 2009;89B (2):536-542.
48. Kanematsu, A., A. Marui, S. Yamamoto, M. Ozeki, Y. Hirano, M. Yamamoto, O. Ogawa, M. Komeda, and Y. Tabata. Type I collagen can function as a reservoir of basic fibroblast growth factor.J. Control. Release 2004;99(2):281-292.
49. Kanematsu, A., S. Yamamoto, M. Ozeki, T. Noguchi, I. Kanatani, O. Ogawa, and Y. Tabata. Collagenous matrices as release carriers of exogenous growth factors. Biomaterials 2004;25(18):4513-4520.
50. Sun, B., B. Chen, Y. Zhao, W. Sun, K. Chen, J. Zhang, Z. Wei, Z. Xiao, and J. Dai. Crosslinking heparin to collagen scaffolds for the delivery of human platelet-derived growth factor.J. Biomed. Mater. Res. B Appl. Biomater. 2009;91(1):366-372.
51. Swieringa, A.J., J.H. Goosen, F.G. Jansman, and N.J. Tulp. In vivo pharmacokinetics of a gentamicin-loaded collagen sponge in acute periprosthetic infection: serum values in 19 patients. Acta Orthop. 2008;79(5):637-642.
52. Griffis, C.D., S. Metcalfe, F.L. Bowling, A.J. Boulton, D.G. Armstrong. The use of gentamycin-impregnated foam in the management of diabetic foot infections: A promising delivery system? Expert Opin. Drug Deliv. 2009;6(6):639-642.
53. Sripriya, R., M.S. Kumar, M.R. Ahmed, and P.K. Sehgal. Collagen bilayer dressing with ciprofloxacin, an effective system for infected wound healing.J. Biomater. Sci. Polym. Ed. 2007;18(3):335-351.
54. Shanmugasundaram, N., T.S. Uma, T.S. Ramyaa Lakshmi, and M. Babu. Efficiency of controlled topical delivery of silver sulfadiazine in infected burn wounds.J. Biomed. Mater. Res. A 2009;89(2):472-482.
55. Wu, W.C., C.C. Lai, H.S. Chen, M.H. Sun, L.M. Lee, C.P. Shih, H.W. Lee, and W.C. Hsu. Efficacy and safety of biodegradable collagen-glycosaminoglycan polymer as a material for scleral buckling. Invest. Ophthalmol. Vis. Sci. 2008; 49(6):2673-2678.
56. Barrett, S.A. and K. Moore. Use of Promogran to treat venous leg ulcers.J. Wound Care 2004;13(1):suppl 2-7.
57. Guarnera, G. and A. Restuccia. Promogran and complex surgical lesions: A case report.J. Wound Care 2004;13(6):237-239.
58. Durrani, O.M., A.I. Fernando, and T.Q. Reuser. Use of a novel topical hemostatic sealant in lacrimal surgery: a prospective, comparative study. Ophthal. Plast. Reconstr. Surg. 2007;23(1):25-27.
59. Geiger, M., R.H. Li, and W. Friess. Collagen sponges for bone regeneration with rhBMP-2. Adv. Drug Deliv. Rev. 2003;55(12):1613-1629.
60. Glatt, V., F.N. Kwong, K. Park, N. Parry, D. Griffin, M. Vrahas, C.H. Evans, and M. Harris. Ability of recombinant human bone morphogenetic protein 2 to enhance bone healing in the presence of tobramycin: Evaluation in a rat segmental defect model.J. Orthop. Trauma 2009;23(10):693-701.
61. Tan, W., J. Xu, Y. Liu, J. Lin, and H. Wang. [Preparation and osteoinduction capacity of collagen/bone morphogenetic protein composites]. Sheng Wu Gong Cheng Xue Bao 2008;24(2):272-277.
62. Visser, R., P.M. Arrabal, J. Becerra, U. Rinas, and M. Cifuentes. The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo. Biomaterials 2009;30(11):2032-2037.
63. Hertz, A. and I.J. Bruce. Inorganic materials for bone repair or replacement applications. Nanomed. 2007;2(6):899-918.
64. McKay, B. Local sustained delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Conf. Proc. IEEE Eng. Med. Biol. Soc. 2009;1:236-237.
65. Cardaropoli, D., S. Re, W. Manuzzi, L. Gaveglio, and G. Cardaropoli. Bio-Oss collagen and orthodontic movement for the treatment of infrabony defects in the esthetic zone. Int.J. Periodontics Restorative Dent. 2006;26(6):553-559.
66. Sun, J. and Q. Liu. [Bio-Oss collagen bone grafting in the treatment of endodonticperiodontic lesion]. Nan Fang Yi Ke Da Xue Xue Bao 2009;29(9):1905-1906.
67. Benjamin, M. and J.R. Ralphs. Fibrocartilage in tendons and ligaments-an adaptation to compressive load.J. Anat. 1998;193(Pt 4):481-494.
68. Windsor, M.L., M. Eisenberg, C. Gordon-Thomson, and G.P. Moore. A novel model of wound healing in the SCID mouse using a cultured human skin substitute. Australas.J. Dermatol. 2009;50(1):29-35.
69. Morimoto, N., S. Takemoto, T. Kawazoe, S. Suzuki, K. Tomihata, and T. Taira. In vivo culturing of a bilayered dermal substitute with adipo-stromal cells.J. Surg. Res. 2008;146(2):246-253.
70. Hu, K.K., Y.C. Dai, J. Li, Y. Lei, J.D. Yuan, J. Li, and Q. Wu. [Construction of a tissue engineering skin with epidermal stem cells]. Zhonghua Zheng Xing Wai Ke Za Zhi 2007;23(1):25-28.
71. Dinh, T.L. and A. Veves. The efficacy of Apligraf in the treatment of diabetic foot ulcers. Plast. Reconstr. Surg. 2006;117(7 Suppl):152S-157S; discussion 158S-159S.
72. Still, J., P. Glat, P. Silverstein, J. Griswold, and D. Mozingo. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 2003;29(8):837-841.
73. Suzuki, K., A. Kawauchi, T. Nakamura, S. Itoi, T. Ito, J. So, O. Ukimura, A. Hagiwara, H. Yamagishi, and T. Miki. Histologic and electrophysiological study of nerve regeneration using a polyglycolic acid-collagen nerve conduit filled with collagen sponge in canine model. Urology 2009;74(4):958-963.
74. Yao, C.C., P. Yao, H. Wu, and Z.G. Zha. Absorbable collagen sponge combined with recombinant human basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve.J. Mater. Sci. Mater. Med. 2007;18(10):1969-1972.
75. Ruszczak, Z. and W. Friess. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv. Drug Deliv. Rev. 2003;55(12):1679-1698.
76. Singisetti, K.K. and G.P. Ashcroft. Intramedullary delivery of Collatamp in long bone infections: a simple innovative technique. Ann.R. Coll. Surg. Engl. 2009;91 (5):437.
77. Maeda, M., S. Tani, A. Sano, and K. Fujioka. Microstructure and release characteristics of the minipellet, a collagen-based drug delivery system for controlled release of protein drugs.J. Control. Release 1999;62(3):313-324.
78. Maeda, H., A. Sano, and K. Fujioka. Controlled release of rhBMP-2 from collagen minipellet and the relationship between release profile and ectopic bone formation. Int.J. Pharm. 2004;275(1-2):109-122.
79. Wallace, D.G. and J. Rosenblatt. Collagen gel systems for sustained delivery and tissue engineering. Adv. Drug Deliv. Rev. 2003;55(12):1631-1649.
80. Sano, A., M. Maeda, S. Nagahara, T. Ochiya, K. Honma, H. Itoh, T. Miyata, and K. Fujioka. Atelocollagen for protein and gene delivery. Adv. Drug Deliv. Rev. 2003;55(12):1651-1677.
81. Usas, A., A.M. Ho, G.M. Cooper, A. Olshanski, H. Peng, and J. Huard. Bone regeneration mediated by BMP4-expressing muscle-derived stem cells is affected by delivery system. Tissue Eng. Part A 2009;15(2):285-293.
82. Zheng, L., J. Sun, X. Chen, G. Wang, B. Jiang, H. Fan, and X. Zhang. In vivo cartilage engineering with collagen hydrogel and allogenous chondrocytes after diffusion chamber implantation in immunocompetent host. Tissue Eng. Part A 2009;15(8):2145-2153.
83. Sultana, Y., R. Jain, M. Aqil, and A. Ali. Review of ocular drug delivery. Curr. Drug Deliv. 2006;3(2):207-217.
84. Friess, W. Collagen-biomaterial for drug delivery. Eur.J. Pharm. Biopharm. 1998;45(2):113-136.
85. Kleinmann, G., S. Larson, B. Hunter, S. Stevens, N. Mamalis, and R.J. Olson. Collagen shields as a drug delivery system for the fourth-generation fluoroquinolones. Ophthalmologica 2007;221(1):51-56.
86. Liu, W., M. Griffith, and F. Li. Alginate microsphere-collagen composite hydrogel for ocular drug delivery and implantation.J. Mater. Sci. Mater. Med. 2008;19 (11):3365-3371.
87. Borene, M.L., V.H. Barocas, and A. Hubel. Mechanical and cellular changes during compaction of a collagen-sponge-based corneal stromal equivalent. Ann. Biomed. Eng. 2004;32(2):274-283.